Why the study?
Do troponins and natriuretic peptides help detect cancer therapy-induced cardiotoxicity in cardio-oncology patients?
Do troponins and natriuretic peptides help detect cancer therapy-induced cardiotoxicity in cardio-oncology patients?
Troponins and natriuretic peptides are important for detecting cardiotoxicity induced by cancer therapy.
Answers are grounded in this paper and cite their sources.
Supports biomarker monitoring in cardio-oncology; leaves open optimal thresholds and RCT-guided implementation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hinrichs et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: